Авторы

  • Abdullaev T.A., Tsoy I.A., Kholikova A.O., Rakhmatov M.M., Yokubdjanov A.O.

Ключевые слова:

Heart failure, bioimpedansometry, hospitalizations, lean body mass.

Библиографические ссылки

1. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure. Lancet. 2011;377(9766):658-666. doi:10.1016/S0140-6736(11)60101-3

2. Brahmbhatt DH, Cowie MR. Remote Management of Heart Failure: An Overview of Telemonitoring Technologies. Card Fail Rev. 2019;5(2):86-92. doi:10.15420/cfr.2019.5.3

3. Czapla M, Surma S, Kwaśny A, Lewandowski Ł. Association of Body Mass Index with Outcomes in Patients with HFrEF. Nutrients. 2024;16(15):2473. doi:10.3390/nu16152473

4. Feldman T, Mauri L, Kahwash R, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure (REDUCE LAP-HF I). Circulation. 2018; 137(4):364-375. doi:10.1161 /CIRCULATIONAHA.117.032094

5. Hamdan A, Shapira Y, Bengal T, et al. Tissue Doppler imaging in patients with advanced heart failure. J Heart Lung Transplant. 2006;25(2):214-218. doi:10.1016/j.healun.2005.09.002

6. Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME). Lancet. 2014;384(9943):583-590. doi:10.1016/S0140-6736(14)61176-4

7. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function. J Am Coll Cardiol. 2004;44(5):1025-1029. doi:10.1016/j.jacc. 2004.05.077

8. Koehler F, Koehler K, Deckwart O, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2). Lancet. 2018;392(10152):1047-1057. doi:10.1016/S0140-6736(18)31880-4

9. Konishi M, Akiyama E, Matsuzawa Y, et al. Prognostic impact of muscle and fat mass in patients with heart failure. J Cachexia Sarcopenia Muscle. 2021;12(3):568-576. doi:10.1002/jcsm. 12702

10. Mayne KJ, Shemilt R, Keane DF, et al. Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and CKD. J Card Fail. 2022;28(11):1628-1641. doi:10.1016/j.cardfail.2022.08.005

11. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325(21):1468-1475. doi:10.1056/NEJM199111213252103

12. Planinc I, Milicic D, Cikes M. Telemonitoring in Heart Failure Management. Card Fail Rev. 2020;6:e06. doi:10.15420/cfr.2019.12

13. Rodenas-Alesina E, Luis Scolari F, Wang VN, et al. Improved mortality and haemodynamics with milrinone in cardiogenic shock. ESC Heart Fail. 2023;10(4):2577-2587. doi:10.1002/ehf2.14379

14. Shahim B, Kapelios CJ, Savarese G, Lund LH. Global Public Health Burden of Heart Failure: An Updated Review. Card Fail Rev. 2023;9:e11. doi:10.15420/cfr.2023.05

15. Shochat MK, Shotan A, Blondheim DS, et al. Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure (IMPEDANCE-HF Trial). J Card Fail. 2016; 22(9): 713-722. doi:10.1016/j.cardfail.2016.03.015

16. Thanapholsart J, Khan E, Lee GA. A Current Review of the Uses of Bioelectrical Impedance Analysis in Heart Failure Patients. Biol Res Nurs. 2023;25(2):240-249. doi:10.1177/10998004 221132838

17. Theuns DAMJ, Radhoe SP, Brugts JJ. Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators. Sensors (Basel). 2021;21(11):3763. doi:10.3390/s21113763

18. Veenis JF, Brugts JJ. Remote monitoring of chronic heart failure patients. Neth Heart J. 2020;28(1):3-13. doi:10.1007/s12471-019-01342-8

19. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics: results from PARTNERS HF study. J Am Coll Cardiol. 2010;55(17):1803-1810. doi:10.1016/j.jacc. 2009.11.089